Atlas Trials

Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh

Clinical trial NCT05475379 · COMPLETED

Trial details

NCT number
NCT05475379
Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Typhoid
Start date
2022-07-01
Primary completion
2023-06-30
Enrollment
630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.